Palabras claves: clinical trials, Immunotoxicity, Nanomedicine, Nanoparticles, pharmacokinetics, Preclinical, Regulatory aspects
Autores: Altamirano C., Katherine V. López-Aguilar, Leandro Santiago Padilla, Santiago Nelson Vispo, Thelvia I. Ramos Gómez, Toledo J.R., Villacis-Aguirre C.A.